Research Analysts’ Recent Ratings Updates for Cooper Companies (COO)

Several brokerages have updated their recommendations and price targets on shares of Cooper Companies (NASDAQ: COO) in the last few weeks:

• 3/6/2026 – Cooper Companies had its price target lowered by Citigroup Inc. from $88.00 to $87.00. They now have a “neutral” rating on the stock.
• 3/6/2026 – Cooper Companies had its price target raised by Barclays PLC from $98.00 to $103.00. They now have an “overweight” rating on the stock.
• 3/6/2026 – Cooper Companies had its price target raised by Needham & Company LLC from $99.00 to $101.00. They now have a “buy” rating on the stock.
• 3/4/2026 – Cooper Companies was downgraded by Rothschild & Co Redburn from “buy” to “neutral”. They now have a $85.00 price target on the stock.
• 2/28/2026 – Cooper Companies was upgraded by Wall Street Zen from “hold” to “buy”.
• 2/3/2026 – Cooper Companies had its price target lowered by Needham & Company LLC from $100.00 to $99.00. They now have a “buy” rating on the stock.
• 1/30/2026 – Cooper Companies was upgraded by William Blair to “strong-buy”.
• 1/26/2026 – Cooper Companies was given a new $98.00 price target by Barclays PLC. They now have an “overweight” rating on the stock.

Insider Buying and Selling at Cooper Companies

In related news, Director Cynthia L. Lucchese purchased 1,784 shares of the firm’s stock in a transaction dated Monday, December 22nd. The shares were purchased at an average cost of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the transaction, the director directly owned 9,445 shares in the company, valued at approximately $793,946.70. This represents a 23.29% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 2.08% of the stock is currently owned by corporate insiders.

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.